Literature DB >> 15308573

Mechanisms of WASp-mediated hematologic and immunologic disease.

Siobhan Burns1, Giles O Cory, William Vainchenker, Adrian J Thrasher.   

Abstract

The Wiskott-Aldrich syndrome protein (WASp) is a key regulator of actin polymerization in hematopoietic cells. The dynamic nature of cytoskeletal changes during a variety of cellular processes demands complex mechanisms for coordinated integration of input signals, precise localization within the cell, and regulated activation of the Arp2/3 complex. Mutations in the Wiskott-Aldrich syndrome gene either inhibit or dysregulate normal WASp function, resulting in clinical diseases with complex and disparate phenotypes. This review highlights recent advances that have enhanced our understanding of the mechanisms by which these molecular defects cause hematologic and immunologic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308573     DOI: 10.1182/blood-2004-04-1678

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Clinical significance and expression of the PRSS3 and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 for the early detection of epithelial ovarian cancer.

Authors:  Sima Azizmohammadi; Aghdas Safari; Mehri Seifoleslami; Rahman Ghaffarzadegan Rabati; Mohsen Mohammadi; Hamid Yahaghi; Susan Azizmohammadi
Journal:  Tumour Biol       Date:  2015-12-10

Review 2.  Wiskott-Aldrich syndrome: another piece in the puzzle.

Authors:  L D Notarangelo; L Mori
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

3.  Wash functions downstream of Rho and links linear and branched actin nucleation factors.

Authors:  Raymond Liu; Maria Teresa Abreu-Blanco; Kevin C Barry; Elena V Linardopoulou; Gregory E Osborn; Susan M Parkhurst
Journal:  Development       Date:  2009-08       Impact factor: 6.868

4.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Authors:  Lisa S Westerberg; Miguel A de la Fuente; Fredrik Wermeling; Hans D Ochs; Mikael C I Karlsson; Scott B Snapper; Luigi D Notarangelo
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

Review 5.  RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy.

Authors:  Fang Cheng; Song He
Journal:  Mol Biol Rep       Date:  2009-09-12       Impact factor: 2.316

6.  Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia.

Authors:  Hirozumi Sano; Ryoji Kobayashi; Daisuke Suzuki; Kazue Yasuda; Masanori Nakanishi; Tetsuro Nagashima; Masafumi Yamada; Kunihiko Kobayashi
Journal:  Int J Hematol       Date:  2012-06-27       Impact factor: 2.490

7.  Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.

Authors:  Stephanie Humblet-Baron; Blythe Sather; Stephanie Anover; Shirly Becker-Herman; Debora J Kasprowicz; Socheath Khim; Thuc Nguyen; Kelly Hudkins-Loya; Charles E Alpers; Steve F Ziegler; Hans Ochs; Troy Torgerson; Daniel J Campbell; David J Rawlings
Journal:  J Clin Invest       Date:  2007-01-11       Impact factor: 14.808

8.  Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.

Authors:  Amanda Prislovsky; Bindumadhav Marathe; Amira Hosni; Alyssa L Bolen; Falk Nimmerjahn; Carl W Jackson; Darryl Weiman; Ted S Strom
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

9.  Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factor.

Authors:  Sabine Charrier; Michael Blundell; Gregory Cédrone; Fawzia Louache; William Vainchenker; Adrian J Thrasher; Anne Galy
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

Review 10.  Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation.

Authors:  Gerben Bouma; Siobhan O Burns; Adrian J Thrasher
Journal:  Immunobiology       Date:  2009-07-22       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.